• 제목/요약/키워드: Damage symptoms

검색결과 465건 처리시간 0.03초

사염화탄소를 투여한 흰쥐에서 인진쑥 및 동충하초의 지질대사촉진 및 간독성저하효과 (Artemisia capillaris and Paecilomyces japonica Stimulate Lipid Metabolism and Reduce Hepatotoxicity Induced by Carbon Tetrachloride in Rats)

  • 김영섭;유윤숙;한은경;강일준;정차권
    • 한국식품영양과학회지
    • /
    • 제37권5호
    • /
    • pp.548-554
    • /
    • 2008
  • 본 연구는 $CCI_4$를 투여한 흰쥐에서 인진쑥과 동충하초를 서로 다른 혼합비율로 투여했을 때 간 손상에 대한 생리활성 기능을 조사하기 위해 혈청 및 지질대사에 미치는 영향을 측정하였다. 사염화탄소의 투여는 간독성을 나타내 간의 무게 및 ALT, AST 수준을 증가시켰으며 이는 인진쑥과 동충하초의 투여에 의해 개선되며 인진쑥과 동충하초를 병행 투여 시 더욱 효과적인 것으로 나타났다. 사염화탄소 투여로 인해 증가된 혈청 콜레스테롤과 중성지방은 인진쑥, 동충하초의 투여로 저하되었으며 혈청 중성지방은 인진쑥과 동충하초를 동량으로 투여한 군에서 유의적으로 낮게 나타났고, 혈청 콜레스테롤은 전체 인진쑥, 동충하초 투여군에서 모두 유의적으로 감소되었으며 인진쑥과 동충하초를 병행 투여하는 경우 더 효과적인 것으로 나타났다. 또한 동맥경화지수는 사염화탄소의 투여 시 정상식이군보다 유의적으로 증가되었으나 인진쑥, 동충하초의 투여로 감소되었으며 4% 인진쑥과 2% 동충하초 병행 투여가 동맥경화지수를 낮추는데 가장 효율적인 것으로 사료된다. 사염화탄소를 투여한 흰쥐의 간장 내 총 지질과 총 콜레스테롤 및 중성지방의 함량은 정상군보다 증가하였다. 인진쑥, 동충하초의 투여는 사염화 탄소 투여로 높아진 중성지방과 콜레스테롤을 감소하는 효과를 보였으며 4% 인진쑥과 2% 동충하초를 병행 투여 시가장 효과적인 것으로 나타났다. 본 연구 결과에 의하면 인진쑥과 동충하초의 투여는 사염화탄소로 유발된 간 독성을 저하시키며 혈청과 간지질 대사를 개선하는 효과가 있는 것으로 사료되며 간 기능 개선과 지질대사 개선효과를 가지고있는 인진쑥과 동충하초를 단독으로 투여하는 것보다 병행 투여하는 것이 더 효과적이며 그 혼합비율이 4% 인진쑥과 2% 동충하초에서 가장 효율적으로 나타났으나 혼합비율에 대해서는 앞으로 지속적인 연구가 필요하다고 사료된다.

Cisplatin, Carboplatin, Oxaliplatin 투여로 인한 말초신경병증에 대한 평가 (Evaluation of Chemotherapy Induced Peripheral Neuropathy by Cisplatin, Carboplatin and Oxaliplatin)

  • 윤완기;허미정;이옥상;임성실
    • 한국임상약학회지
    • /
    • 제22권4호
    • /
    • pp.356-366
    • /
    • 2012
  • Background: Chemotherapy-induced peripheral neuropathy (CIPN) involving sensory and motor nerve damage or dysfunction is a common and serious clinical problem that affects many patients receiving cancer treatment. This condition may pose challenges for the clinician to diagnose and manage, particularly in patients with coexisting conditions or disorders that involve the peripheral nervous system. Many chemotherapeutic agents used today are associated with the development of serious and dose-limiting CIPN that can adversely affect the administration of planned therapy and can impair quality of life by interference with the patients' activities of daily living. The most important clinical objective in the evaluation of patients with CIPN is to determine their level of functional impairment involving activities of daily living. These findings are used to make medical decisions to continue, modify, delay, or stop treatment. The most commonly reported drugs to cause CIPN include taxanes, platinum agents, vinca alkaloids, thalidomide, and bortezomib. We aimed to determine PN incidence during cisplatin, carboplatin and oxaliplatin administration. Methods: We collected data from 125 patients who received at least one cycle of cisplatin, carboplatin or oxaliplatin. They completed a self-reported questionnaire and items related to their disease and peripheral neuropathy. The investigators filled in part of items about disease and treatment. Patient Neurotoxicity Qeustionnaire developed by Bionumerik company were applied for PN assessment. Results: The incidences of sensory neurotoxicities of cisplatin, carboplatin and oxaliplatin were respectively 23%, 56% and 50%. The incidences of motor neurotoxicities of cisplatin, carboplatin and oxaliplatin were respectively 18%, 42% and 19%. The incidences of severe neurotoxicities of cisplatin, carboplatin and oxaliplatin were respectively 13%, 28% and 14%. The incidences of PN were associated with cumulative dose but not age, gender and concurrent illness. 19.2% of the patients (24/125) were prescribed with gabapentin, nortriptyline or gabapentin plus nortriptyline to reduce these peripheral symptoms and 75% of the patients answered the drug were effective. Conclusion: Incidence of PN after cisplatin or oxaliplatin administration is cumulative dose-related. Physician-based assessments under-reported the incidence and severity of CIPN. To overcome this limitation, diagnostic tools specifically designed to assess peripheral neuropathy severity associated with chemotherapy must be developed.

Aluminium이 팥(Vigna angularis) 유식물의 생장, 엽록소함량, ALAD활성 및 뿌리와 경엽부의 형태에 미치는 영향 (Effects of Aluminium on Growth, Chlorophyll Content, ALAD Activity and Anatomy of Root rind Shoot in Azuki Bean (Vigna angularis) Seedlings)

  • 구서영;홍정희
    • 한국환경과학회지
    • /
    • 제5권6호
    • /
    • pp.813-826
    • /
    • 1996
  • 발아후 7일된 팥유식물에서 alumlnlum(Al)이 생장, 엽록소 함량, ALAD활성 및 뿌리와 경엽부의 형태에 미치는 영향을 조사하였다. 저농도(50, 100 $\muM)의$ Al처리에 의해 뿌리와 경엽부의 신장이 매우 감소되었으며 농도가 증가함에 따라 생장이 더욱 억제되었다. 따라서 생장억제는 농도의존적이었다. 뿌리신장은 Al 처리 24시간에서 감소되었으며 7일간의 저농도처리에 의해 억제효과가 회복되는 경향을 보여주었다. Al의 독성증상과 생장반응은 경엽부에 비해 뿌리에서 더 크게 나타났다. Hematoxylin 염색법에 의해 Al 분포를 조사한 결과 Al은 근단을 통해 표피와 피층세포에 축적되어 있음을 알 수 있었다. 한편 Al처리는 엽록소함량을 감소시켰으며, ALAD활성 또한 억제시켰다. 엽록소 함량과 ALAD 활성 간에는 양의 상관관계가 나타났다. Al 처리에 의한 뿌리의 형태변화를 보면 표피세포 및 피층세포의 변형 또는 파괴가 관찰되었으며, 뿌리직경과 피층의 체적도 매우 감소되었다. 경엽부에서도 Al처리는 직경과 세포크기의 감소를 보여주었다. 그러나 잎에서의 형태적 변화는 엽록체수와 크기변화 이외에는 거의 관찰되지 않았다. 이와 같은 결과에서 Al의 독성효과는 1차적으로 뿌리에서 나타나며, 뿌리형태의 변화는 뿌리의 생장패턴과 관련이 있음을 알 수 있었다. 따라서 Al은 팥유식물에서 특히 뿌리의 형태와 기능적 손상을 일으키는데 큰 영향을 미치는 것으로 생각된다.

  • PDF

GALT 유전자의 복합 이형 돌연변이에 의한 전형적 갈락토오스혈증 1례 (A Case of Classical Galactosemia caused by Compound Heterozygous Mutations of the GALT Gene)

  • 전종근;조민성;고정민;김구환;유한욱
    • Journal of Genetic Medicine
    • /
    • 제5권2호
    • /
    • pp.131-135
    • /
    • 2008
  • 전형적 갈락토오스혈증(classical galactosemia)은 상염색체 열성으로 유전되는 galactose-1-phosphate uridyltransferase(GALT) 효소의 결핍에 의한 갈락토오스 대사 장애 질환이며 galactose-1-phosphate가 축적되어 간, 뇌, 신경에 심각한 영향을 끼친다. 본 증례는 GALT 효소 결핍 신생아에서, 출생 후 락토오스가 함유된 일반 수유를 시작하면서 심한 황달, 구토, 심한 출혈경향 및 간 부전 등이 발생하였다. 신생아 선별검사에서 갈락토오스의 증가로 재검을 의뢰하였고, 그 사이에 일반수유로 인해 임상증상이 악화 되어 생후 11일째 본원으로 전원되었다. 효소분석검사와 유전자검사로 확진 전에 임상적으로 갈락토오스혈증이 의심이 되어 소이 분유로 수유를 시작하였고, 이후 심한 황달과 출혈경향의 호전, 간기능 호전, 체중 증가와 전신상태가 회복되어 11일간의 입원 이후 퇴원하였다. 갈락토오스혈증의 임상 증상에 대한 올바른 이해를 통해 조기 진단하여 식이요법 등의 치료로 사망률을 줄이고, 유전자검사로 갈락토오스혈증을 확진하여 유전상담 및 산전진단에 유용하게 이용할 수 있는데, 본 증례에서는 효소분석 결과 GALT 효소 결핍증과 유전자검사에서 아직까지 보고된 적이 없는 GALT 유전자의 이형 돌연변이를 경험 하였기에 이를 보고하는 바이다.

  • PDF

Screening of Preventive Effects of Herbal Prescriptions in Rat Model of Arterial Thrombosis Induced by Ferric Chloride

  • Lee, Ki Mo;Bang, Jihye;Lee, In Sun;Heo, Eun Jung;Kim, Bu Yeo;Kang, Hyung Won;Lyu, Yeoung Su;Jeon, Won Kyung
    • 대한한의학회지
    • /
    • 제34권2호
    • /
    • pp.20-28
    • /
    • 2013
  • Objectives: This study examined the effects of 8 types of herbal prescriptions prescribed to alleviate dementia symptoms in a rat model of arterial thrombosis induced by ferric chloride ($FeCl_3$). Methods: Thirty minutes before 35% $FeCl_3$ treatment, SD rats were intraperitoneally injected with the 8 types of herbal prescriptions, respectively. We tested the effects of the herbal prescriptions on time to occlusion (TTO) in an arterial thrombosis model using a laser Doppler flow meter. In addition, thrombus weight (TW) and collagen fiber damages were evaluated in the same condition. Results: Herbal prescriptions showed the following rank-order based on their TTO: Chong-myung-tang (CMT) > modified Jangwonhan 02 (LMK02) > Toki-shakuyaku-san (TSS) ${\geq}$ Oren-gedoku-to (OGT) ${\geq}$ Yokukansan (YKS). In particular, CMT (100 mg/kg, i.p.) and LMK02 (100 mg/kg, i.p.) delayed the TTO the most ($14.83{\pm}0.98$ and $13.67{\pm}1.03$ min, respectively) compared with the vehicle group ($7.95{\pm}0.78$ min, P<0.001). In addition, CMT, LMK02, and OGT treatment ($0.63{\pm}0.01$, $0.66{\pm}0.02$ and $0.67{\pm}0.01$ mg/mm, respectively) significantly reduced thrombus weight compared with the vehicle treatment ($0.78{\pm}0.03$, P<0.001) and also alleviated collagen fiber damage (CMT; $28.40{\pm}2.22$%, LMK02; $30.79 {\pm} 4.07$%, OGT; $26.20{\pm}1.48$%) in the vessels injured by $FeCl_3$. Therefore, CMT and LMK02 showed the greatest preventive activity in rat model of arterial thrombosis induced by $FeCl_3$. Conclusions: These results provide experimental evidence for traditional use of herbal prescriptions, suggesting that CMT and LMK02 extracts could be used to prevent vascular injury and thrombosis in the early stages of dementia.

Hepatitis C Virus - Proteins, Diagnosis, Treatment and New Approaches for Vaccine Development

  • Keyvani, Hossein;Fazlalipour, Mehdi;Monavari, Seyed Hamid Reza;Mollaie, Hamid Reza
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권12호
    • /
    • pp.5917-5935
    • /
    • 2012
  • Background: Hepatitis C virus (HCV) causes acute and chronic human hepatitis infection and as such is an important global health problem. The virus was discovered in the USA in 1989 and it is now known that three to four million people are infected every year, WHO estimating that 3 percent of the 7 billion people worldwide being chronically infected. Humans are the natural hosts of HCV and this virus can eventually lead to permanent liver damage and carcinoma. HCV is a member of the Flaviviridae family and Hepacivirus genus. The diameter of the virus is about 50-60 nm and the virion contains a single-stranded positive RNA approximately 10,000 nucleotides in length and consisting of one ORF which is encapsulated by an external lipid envelope and icosahedral capsid. HCV is a heterogeneous virus, classified into 6 genotypes and more than 50 subtypes. Because of the genome variability, nucleotide sequences of genotypes differ by approximately 31-34%, and by 20-23% among subtypes. Quasi-species of mixed virus populations provide a survival advantage for the virus to create multiple variant genomes and a high rate of generation of variants to allow rapid selection of mutants for new environmental conditions. Direct contact with infected blood and blood products, sexual relationships and availability of injectable drugs have had remarkable effects on HCV epidemiology. Hundreds of thousands of people die each year from hepatitis and liver cancer caused by HCV virus infection. Approximately 80% of patients with acute hepatitis C progress into a chronic disease state leading to serious hepatic disorders, 10-20% of which develop chronic liver cirrhosis and hepatocellular carcinoma. The incubation period of HCV is 6-8 weeks and the infection is often asymptomatic so it is very hard to detect at early stages, making early treatment very difficult. Therefore, hepatitis C is called a "silent disease". Neutralizing antibodies are produced against several HCV proteins during infection but the virus mutates to escape from antibodies. Some patients with chronic hepatitis C may have some symptoms such as fatigue, muscle aches, nausea and pain. Autoimmune and immunecomplex-mediated diseases have also been reported with chronic HCV infection.

Styrene 노출에 반응을 보이는 혈청 단백질에 대한 프로테오믹스 분석 (Proteomic analysis of serum proteins responsive to styrene exposure)

  • 김기웅;허경화;원용림;정진욱;김태균;박인정
    • 한국산업보건학회지
    • /
    • 제17권3호
    • /
    • pp.235-244
    • /
    • 2007
  • By comparing the proteins from the workers exposed to styrene with the ones from controls, it may be possible to identify proteins that play a role in the occurrence and progress of occupational disease and thus to study the molecular mechanisms of occupational disease. In order to find the biomarkers for assessing the styrene effects early, before clinical symptoms develop and to understand the mechanisms of adverse health effects, we surveyed 134 employees, among whom 52 workers(30 male and 22 female) were chronically exposed to styrene in 10 glass-reinforced plastic boat manufacturing factories in Korea and 82 controls had never been occupationally exposed to hazardous chemicals including styrene. The age and drinking habits and serum biochemistry such as total protein, BUN and serum creatinine in both groups were significantly different. Exposed workers were divided into three groups according to exposure levels of styrene(G1, below 1/2 TLV; G2, 1/2 TLV to TLV; G3, above TLV). The mean concentration of airborne styrene in G1 group was $10.93{\pm}11.33ppm$, and those of urinary mandelic acid(MA) and phenylglyoxylic acid(PGA) were $0.17{\pm}0.21$ and $0.13{\pm}0.11g/g$ creatinine, respectively. The mean concentration of airborne styrene in G2 and G3 groups were $47.54{\pm}22.43$ and $65.33{\pm}33.47ppm$, respectively, and levels of urinary metabolites such as MA and PGA increased considerably as expected with the increase in exposure level of styrene. The airborne styrene concentration were significantly correlated to the urinary concentration of MA(r=0.784, p=0.000) and PGA(r=0.626, p<0.001). In the 2D electrophoresis, the concentration of five proteins including complement C3 precursor, alpha-1-antitrypsin(AAT), vitamin D binding protein precursor(DBP), alpha-1-B-glycoprotein(A1BG) and inter alpha trypsin inhibitor(ITI) heavy chain-related protein were significantly altered in workers exposed to styrene compared with controls. While expression of complement C3 precursor and AAT increased by exposure to styrene, expression of DBP, A1BG and ITI heavy chain-related protein decreased. These results suggest that the exposure of styrene might affects levels of plasma proteinase, carriers of endogenous substances and immune system. In particular, increasing of AAT with the increase in exposure level of styrene can explain the tissue damage and inflammation by the imbalance of proteinase/antiproteinase and decrease of DBP, A1BG and ITI heavy chain-related protein in workers exposed to styrene is associated with dysfunction and/or declination in immune system and signal transduction

Methotrexate에 의한 약제 유발 과민성 폐렴 1례 (A Case of Hypersensitivity Pneumonitis Caused by Methotrexate)

  • 서현주;정만표;박은하;신성철;전경만;유창민;편유장;이경수;한정호
    • Tuberculosis and Respiratory Diseases
    • /
    • 제56권2호
    • /
    • pp.203-209
    • /
    • 2004
  • MTX는 골육종이나 진행된 비호치킨씨 임파종과 같은 종양성 질환 뿐아니라 건선이나 류마치스 관절염, 유육종증, 웨그너씨 육아종증등의 양성질환에서도 널리 쓰여지는 약물이다. MTX에 의한 폐독성은 약제를 투여받은 환자들 중 0.3-7.5%정도에서 나타나는 것으로 알려져 있다. 급성 또는 만성의 경과로 나타나는 MTX 폐렴의 예가 기술되어 있지만 전형적으로는 MTX를 투여한지 수개월내에 증상이 나타나는 아급성의 임상경과를 취하는 경우가 많다. 조직병리학적으로는 NSIP의 형태로 나타나는 경우가 가장 흔한 것으로 되어 있으나 BOOP나 DAD로 나타나는 경우도 드물게 보고되고 있으며 그 중 육아종의 형성을 보이는 예는 34.7% 정도로 알려져 있다. 우리나라에서는 NSIP나 DAD로 나타난 MTX 폐장염의 예가 보고되어있다. 저자들은 과민성 폐장염의 형태로 발현한 MTX에 의한 폐독성의 증례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran

  • Honarvar, Behnam;Sayar, Negin;Tahmasebi, Sedigheh;Zakeri, Zeinab;Talei, Asra;Rostami, Sara;Khademi, Sahar;Sarvestani, Amene Sabzi;Sekhavati, Eghbal
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권sup3호
    • /
    • pp.81-85
    • /
    • 2016
  • Globally, the burden of breast cancer (BC) continues to increase. BC related lymphedema (BCRL) is currently non curable and as a life time risk it affects at least 25% of BC patients. Knowing more about BCRL and appropriate control of its modifiable risk factors can improve quality of life (QOL) of the affected patients. In this case control study to detect factors, 400 women with BCRL (as the case group) and 283 patients with BC without lymphedema (as the control group) that were referred to Shiraz University of Medical Sciences affiliated BC clinic center were assessed. The data were analyzed in SPSS. The mean age of the case group was $52.3{\pm}11.0years$ and of the control group was $50.1{\pm}10.9years$. In patients with BCRL, 203(50.7%) had left (Lt) side BC and in non- lymphedema group 151 (53.3%) had Lt side BC. Out of all BCRL patients, 204 (51%) had lymphedema in all parts of their affected upper extremities, 100 (25%) had swelling in the arm and forearm and 23 (5.7%) had edema in both the upper extremity and trunk. Edema, heaviness, concern about changing body image, pain and paresthesia were the most common signs/symptoms among patients with BCRL. In BCRL patients, the difference of circumference between the affected upper limb and non-affected limb was $4.4{\pm}2.5cm$ and the difference in volume displacement was $528.7{\pm}374.4milliliters$. Multiple variable analysis showed that moderate to severe activity (OR; odds ratio =14, 95% CI :2.6-73.3), invasiveness of BC (OR =13.7, 95% CI :7.3-25.6), modified radical mastectomy (OR=4.3, 95% CI :2.3-7.9), BMI =>25 (OR=4.2, 95% CI :2-8.7), radiotherapy (OR=3.9, 95% CI :1.8-8.2), past history of limb damage (OR=1.7, 95% CI :0.9-3.1) and the number of excised lymph nodes (OR=1.06, 95% CI :1.02-1.09) were the significant predictors of lymphedema in women with BC. Modifiable risk factors of BCRL such as non-guided moderate to severe physical activity, high BMI and trauma to the limb should be controlled as early as possible in BC patients to prevent development of BCRL and improve QOL of these patients.

하악 제3대구치 발치의 결정에 관한 재고찰 - 발치 현황과 영향 인자를 중심으로 (Reconsideration of decision making for third molar extraction)

  • 박원서;김진학;강상훈;김문기;김봉철;최지욱;이상휘
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제37권5호
    • /
    • pp.343-348
    • /
    • 2011
  • Introduction: Third molar extraction is one of the most common procedures in oral and maxillofacial surgery. The impacted third molar causes many pathological conditions, such as pericoronitis, caries, periodontitis, resorption of adjacent teeth, and cyst or tumors associated with impacted teeth. Extraction is often considered the treatment of choice for impacted lower third molars. On the other hand, imprudent extraction of deeply impacted third molars can cause permanent complications, such as inferior alveolar nerve damage. Therefore, guidelines for the extraction of lower third molars should be set to prevent embarrassing complications. This study examined the indication and current trends of the extracted lower third molars in the dental hospital of a dental college. Materials and Methods: 557 extracted third molars were evaluated at the department of oral and maxillofacial surgery of Yonsei University. The chief complaint, diagnosis, age and degree of impaction were analyzed to determine the tendency for the extraction of asymptomatic lower third molars. Results: The percentage of asymptomatic third molars was 40.8%. In cases of full impacted tooth or full erupted tooth, the percentage of asymptomatic teeth was more than 50% (52.4% and 54.3, respectively). Among those partially impacted teeth, 73.1% of them showed symptoms, such as pain, tenderness and swelling. In terms of age, pericoronitis was evident at a younger age, and dental caries/periodontitis was the main cause of removal in those aged over 50. Twenty nine cases (1.6%) had teeth associated with pathological changes Conclusion: The incidence of pathological changes to the lower third molar was relatively low. Surgical extraction is recommended in cases of partially impacted teeth. In Korea, the incidence of asymptomatic third molar extraction was relatively higher than in European countries. More careful attention would be desirable to consider the risks and benefits of lower third molar extraction.